Eight patients, who developed acute chest pain and ST-segment elevation within the first few days of coronary stenting, were administered 1.5 million units of streptokinase or urokinase and followed up for acute and long-term events.
RESULTS:
Seven patients responded well. The ST-segment resolution was excellent and the clinical outcome good. One patientwho presented late after the onset of chest pain and received urokinase, expired.